About PIC S
PIC S is a company based in Geneve (Switzerland) founded in 1995. PIC S offers products and services including PIA Academy and Guidelines. PIC S operates in a competitive market with competitors including ProPharma Group, Validant, PharmaLex, Technical Safety Services and Celegence, among others.
- Headquarter Geneve, Switzerland
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website picscheme.org
- Social LinkedIn
- Latest Funding Round$62.34K (USD), Grant
Dec 2014
- Investors
Products & Services of PIC S
PIC S offers a comprehensive portfolio of products and services, including PIA Academy and Guidelines.
Web-based center for harmonized GMP training internationally
Documents outlining harmonized GMP standards for inspectorates
Funding Insights of PIC S
- Total Rounds 1
- Last Round Grant — $62,340
- First Round $62,340
(Dec 2014)
- Investors Count 1
All 1 funding rounds of PIC S with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2014 | $62,340 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in PIC S
PIC S has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for PIC S
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of PIC S
2 dated milestones of PIC S across 19 years, from founding to its latest funding, stage changes and deals.
- Founded PIC S is founded.
- Funding First funding round of $62K.
Competitors of PIC S
PIC S operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ProPharma Group, Validant, PharmaLex, Technical Safety Services and Celegence, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| propharmagroup.com | 2001 | Saint Paul, United States | – | 999 | Provider of regulatory compliance solutions to pharmaceutical, biotechnology and medical device | |
| validant.com | 2005 | San Francisco, United States | $2.28M | – | Regulatory, compliance, and quality consulting for GxP lifecycles is provided. | |
| pharmalex.com | 1998 | Mannheim, Germany | – | 310 | CRO specializing in regulatory affairs and pharmacovigilance | |
| techsafety.com | 1970 | Berkeley, United States | – | 71 | Healthcare instrumentation, medical gas systems, and related devices are manufactured. | |
| celegence.com | 2017 | Downers Grove, United States | – | – | Regulatory consulting and solutions for pharmaceuticals and medical devices compliance. | |
| clinoutsolutions.com | 2013 | Tucson, United States | – | 38 | Regulatory support and consulting services are provided for clinical outcomes. | |
| mapigroup.com | 1990 | Lyon, France | $8.43M | – | Real world evidence and post-approval research services are provided. | |
| trasis.com | 2004 | Ans, Belgium | – | 218 | Provides radiopharmaceutical equipment, synthesis solutions, and custom services for labs. | |
| flyingbrands.co.uk | 1981 | Chelmsford, United Kingdom | – | – | Regulatory services are provided to the biopharma sector. | |
| pharmabioserv.com | 1993 | Dorado, Puerto Rico | $11.75M | – | Provider of regulatory compliance and validation support to life science industries |
Detailed competitors of PIC S
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of PIC S
The website of PIC S (picscheme.org) receives about 37.5K visits a month and ranks #671,362 among all websites worldwide, #750 in Biotechnology and Pharmaceuticals.
- Monthly visits37.5K
▼ 12.4% vs previous month
- Unique visitors18.3K
per month
- Global rank#671,362
among all websites
- Category rank#750
Health · Biotechnology and Pharmaceuticals
- Bounce rate37%
- Pages per visit2.5
- Average visit49 sec
- DevicesDesktop 37% · Mobile 63%
Websites whose visitors overlap most with PIC S. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| ich.org | 100% | 267.4K | #205,865 | View details | |
| camargopharma.com | 100% | – | – | View details | |
| comecer.com | 84% | 22.6K | #1,278,572 | View details | |
| efpia.eu | 60% | 89.3K | #445,999 | View details |
Similar companies to PIC S
10 companies that operate in the same segment as PIC S (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PIC S
PIC S was founded in 1995 and raised its 1st funding round 19 years after it was founded.
PIC S is headquartered in Geneve, Switzerland. It is registered at Geneve, Geneve, Switzerland.
PIC S was established in 1995 in Geneva, Switzerland, as an international body focused on pharmaceutical inspection standards. Regulatory support services are delivered to the biopharma sector, including guidance on good manufacturing practices and inspection harmonization. Operations span global cooperation among regulatory authorities, with resources accessible via picscheme.org. Emphasis is placed on ensuring compliance and quality in pharmaceutical production across member countries.
PIC S's top competitors include ProPharma Group, PharmaLex and Pharma-Bio Serv.
PIC S offers PIA Academy and Guidelines.
PIC S has 1 investor. Key investors include European Union.